(HRTX)

Reporting relationship: EVP, Chief Development Officer
Issuer ticker: HRTX
Reported as of: 06 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 08 Jun 2026, 10:27:48 UTC
Prior SEC filing: 04 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Kathryn Lester Attorney-in-Fact for William P. Forbes

Key filing fact

William P. Forbes filed Form 4 for HERON THERAPEUTICS, INC. /DE/ (HRTX) on 08 Jun 2026.

Key facts

This page summarizes William P. Forbes's Form 4 filing for HERON THERAPEUTICS, INC. /DE/ (HRTX).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 08 Jun 2026, 10:27.

Change

Previous filing in this sequence was filed on 04 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001314760 Primary reporting owner

Forbes William P

Relationship: EVP, Chief Development Officer
Address: 25 FENTON MAIN STREET, SUITE 300, CARY
Signature: /s/ Kathryn Lester Attorney-in-Fact for William P. Forbes
Signature date: 08 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HRTX transaction

Common Stock

Options Exercise

Transaction value
Shares: +12,500
Change %: +6%
Price
Shares after: 221,611
Date: 06 Jun 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HRTX transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -12,500
Change %: -50%
Price: $0.000000^*
Shares after: 12,500
Date: 06 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 12,500
Exercise price: $0.000000
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of common stock.

Footnote F2

The restricted stock units vest in four equal annual installments beginning one year after the date of grant, subject to the Reporting Person's continued service to the Issuer through the vesting date.